Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails | |
---|---|---|---|---|---|---|---|---|
2024-12-16 | 2024-12-12 |
Apogee Therapeutics Inc
(APGE)
|
A Achat |
12 500
+166.7%
49,85623 125 USD |
12 500 +166.7% | 49,85 | 623 125 USD | |
2024-12-16 | 2024-12-12 |
Apogee Therapeutics Inc
(APGE)
|
A Achat |
7 500
+inf%
49,02367 650 USD |
7 500 +inf% | 49,02 | 367 650 USD | |
2023-03-17 | 2023-03-15 |
Prometheus Biosciences Inc
(RXDX)
|
VP Vente planifiée |
25 000
-31.2%
116,142 903 500 USD |
25 000 -31.2% | 116,14 | 2 903 500 USD | |
2023-03-03 | 2023-03-03 |
Prometheus Biosciences Inc
(RXDX)
|
VP Vente planifiée |
10 620
-16.1%
125,131 328 881 USD |
10 620 -16.1% | 125,13 | 1 328 881 USD | |
2023-03-03 | 2023-03-01 |
Prometheus Biosciences Inc
(RXDX)
|
VP Vente planifiée |
700
-1.3%
125,2687 682 USD |
700 -1.3% | 125,26 | 87 682 USD | |
2023-02-17 | 2023-02-17 |
Prometheus Biosciences Inc
(RXDX)
|
VP Vente planifiée |
13 680
-19.9%
125,101 711 368 USD |
13 680 -19.9% | 125,10 | 1 711 368 USD | |
2023-02-17 | 2023-02-16 |
Prometheus Biosciences Inc
(RXDX)
|
VP Vente planifiée |
25 000
-31.2%
119,872 996 750 USD |
25 000 -31.2% | 119,87 | 2 996 750 USD | |
2023-02-17 | 2023-02-15 |
Prometheus Biosciences Inc
(RXDX)
|
VP Vente planifiée |
25 000
-31.2%
119,422 985 500 USD |
25 000 -31.2% | 119,42 | 2 985 500 USD | |
2023-01-19 | 2023-01-17 |
Prometheus Biosciences Inc
(RXDX)
|
VP Vente planifiée |
25 000
-31.2%
118,992 974 750 USD |
25 000 -31.2% | 118,99 | 2 974 750 USD |
// ... existing code ... // ... rest of the file ...